Technology for Cancer Drug Delivering Nanoparticle Manufacturing

International Cancer and Ion Channels Congress

On September 17th, Microfluidics participated in the 3rd International Cancer and Ion Channels Congress. The event was held virtually with a delegation of speakers presenting on a range of topics from cancer metabolism, translational oncology and ion channels. This event hosted 25 sessions for global scientists from academia and industry, interested in interdisciplinary research and education in the fields of cancer research and clinical oncology.

During the event, Yang Su, Ph.D. (Manager of New Technology and Applications at Microfluidics International Corporation) presented:

Topics of this discussion included:

• Drug delivering nanoparticles and challenges during development and manufacturing.
• Overall benefits of Microfluidizer^® technology for addressing nanotechnology applications.
• Microfluidizer^® technology's role in solving the challenges in producing various nanoparticle platforms such as RNA/lipid nanoparticles, nanoemulsions, liposomes, and Nanoparticle albumin-bound (NAB) drug delivery.
  
  

You can view a recording of the presentation below:

Drug Delivery Resources

View our Resource Centre to learn more about the development and production of drug delivery using Liposomes, Lipid Nanoparticles, and Nanoparticle Albumin Bound Paclitaxel.